Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Monroe, LA MSA — September 2026
Monroe's validation engineers command a 53% pay premium over the nation.
Validation Engineer pay hit a $165,360 metro median versus $108,377 nationally, even as Regulatory Affairs Specialist pay slipped to $98,612 against a flat $104,000 national figure.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Monroe MSA unemployment rate: 4.2% — Steady vs. Louisiana's 4.2%-4.4% statewide range
- Validation Engineer pay premium: $165,360 — vs. $108,377 national median, up significantly
- Regulatory Affairs pay divergence: $98,612 — Down moderately vs. flat $104,000 national median
- Louisiana generic pharma manufacturing jobs: 79 workers — Declining 10.4% annually statewide
Key takeaways
Validation Engineer pay is outrunning the national market by 53%.
Metro median of $165,360 against a national figure of $108,377 suggests Monroe employers are competing hard for a narrow local pool of qualified engineers, likely tied to manufacturing and quality investment in the region. Treat this role as a flight risk category and benchmark offers frequently rather than relying on annual cycles.
Regulatory Affairs pay is softening locally while the national market holds firm.
Metro median regulatory affairs pay fell to $98,612, trailing the stable $104,000 national figure, even as national commentary describes regulatory talent as a critical bottleneck. This divergence may reflect fewer regulatory-intensive employers locally rather than easing demand — a signal to verify before assuming reduced scarcity.
Clinical research pay keeps climbing, outpacing national growth.
Clinical Research Associate median reached $97,646 locally, above the $90,956 national figure, with both trending up significantly. Louisiana's thin life sciences talent density likely forces local employers to pay a premium simply to retain clinical operations staff who could otherwise migrate to larger regional hubs.
Louisiana's generic pharma manufacturing base keeps shrinking.
Statewide generic pharmaceutical manufacturing employment sits at just 79 workers, declining 10.4% annually, reinforcing that build strategies face a structurally weak local foundation. CDMO and CRO partnerships likely remain the more realistic path for Monroe-area manufacturing scale-up over the next planning cycle.
Median advertised pay by role — Monroe, LA MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $82,152 | $132,964 | $150,000 | Significant increase | $131,354 |
| Clinical Research Associate * | $73,458 | $97,646 | $101,465 | Significant increase | $90,956 |
| Lab Technician * | $39,780 | $45,760 | $51,465 | Moderate decline | $47,402 |
| Regulatory Affairs Specialist * | $72,732 | $98,612 | $116,373 | Moderate decline | $104,000 |
| Clinical Data Manager * | $96,750 | $127,578 | $142,800 | Moderate decline | $123,031 |
| Biostatistician * | $107,702 | $128,494 | $155,013 | Stable | $133,322 |
| Validation Engineer * | $97,024 | $165,360 | $172,800 | Significant increase | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Monroe MSA unemployment held at 4.2% in September, with nonfarm payrolls stable and little month-over-month movement across major industries, consistent with Louisiana's broader stabilization near 4.2%-4.4%. Local labor supply remains thin for credentialed scientific and technical roles, since the metro's life sciences footprint stays concentrated in healthcare delivery and clinical services rather than R&D, manufacturing, or regulatory functions that drive specialized hiring elsewhere in the state.
What it means
Validation Engineer pay rising to a $165,360 metro median — well above the $108,377 national figure — signals that Monroe-area device and manufacturing-adjacent employers are bidding up a thin local bench rather than benefiting from any regional talent surplus, a dynamic distinct from coastal hubs where supply is deeper. With Regulatory Affairs Specialist and Clinical Data Manager pay both softening locally against flat-to-rising national trends, leaders face a bifurcated market where execution-critical technical roles command premiums while administrative-adjacent functions lose pricing power. Consider reviewing whether Monroe-based regulatory and data management roles can be restructured toward remote or hybrid models to access deeper talent pools, while reserving premium local pay for roles — like validation and manufacturing engineering — that require physical presence.
Looking ahead
Worth watching: Louisiana's October 20 BLS release will update Monroe-specific unemployment and payroll figures; watch whether the 4.2% rate holds or whether seasonal manufacturing and healthcare hiring shifts it either direction.
Emerging pressure point: National biopharma layoffs (BioMarin, Bristol Myers) are concentrated in consolidation functions, not execution roles — Louisiana life sciences employers should watch whether any displaced regulatory or CMC talent becomes available for remote or relocated hires into Monroe-based roles.
Potential inflection point: Validation Engineer pay's sharp local premium could attract candidates from outside the metro if sustained, but may also signal unsustainable bidding if driven by one or two employers competing for the same small pool — worth tracking whether the premium persists into Q4 postings.
Early indicator: Louisiana's professional, scientific, and technical services sector grew just 1.14% year-over-year through June, modest growth that may mask continued scarcity in biotech-specific subfunctions. Monitor whether Q3 data shows acceleration tied to petrochemical and advanced manufacturing investment spilling into adjacent technical hiring.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.